You are using an older browser version. Please use a supported version for the best MSN experience.

Novartis halts distribution of generic heartburn medication

The maker of a generic version of Zantac is halting distribution. It comes after an FDA warning about a possible cancer-causing chemical found in Zantac and related heartburn medications. Dr. Jon LaPook explains.
image beaconimage beaconimage beacon